Hirotaka Komaba is an expert in Nephrology at Tokai University Hospital (Japan). As of September 2026, ScienceLeadR ranks Hirotaka Komaba in the top 1% of experts worldwide for Parathyroid Diseases. Hirotaka Komaba has authored 205 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 725 (community average: 125). How the SLR is computed.

LeadR Profile

Hirotaka Komaba Tokai University Hospital Japan
725 ScienceLeadR Reputation 725
Network Map

Nephrology

Subspecialties: Endocrinology - Transplantation - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Tokai University School of Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 205

Citations

Citations: 5 918 1st author: 70 Last author: 15 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
FGF23 regulates phosphate and vitamin D metabolism during acute kidney injury and recovery.
PMID 42721953 — vitamin d, growth, vitamins, recycling, kidney, reperfusion injury, fibroblasts, fibroblast growth factors, hyperphosphatemia, hyperparathyroidism, acute kidney injury, hyperparathyroidism, secondary
Am J Physiol Renal Physiol20260
KDIGO Workshop Report on the Implementation and Expansion of Home Hemodialysis in East Asia: A Focus on Hong Kong, Japan, Korea, and Taiwan.
PMID 42518526 — hemodialysis, home, kidney, therapeutics
Kidney Int Rep20260
Serum activin A and bone metabolism in patients undergoing hemodialysis.
PMID 42463974 — parathyroid hormone, cells, alkaline phosphatase, serum, bone remodeling, kidney, hormones, phosphoric monoester hydrolases, osteoporosis, history, bone density, activins, osteoclasts
Osteoporos Int20260
Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease.
PMID 42366630 — kidney diseases, proteinuria, creatinine, albuminuria, cohort studies, kidney, nephrology, kidney transplantation, renal insufficiency, chronic
Nephrol Dial Transplant20260
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
PMID 42246414 — kidney diseases, creatinine, albuminuria, kidney
JAMA Top journal20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3

By status:

Completed 3

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map